Amedisys Inc (NAS:AMED)
$ 94.43 -0.52 (-0.55%) Market Cap: 3.09 Bil Enterprise Value: 3.48 Bil PE Ratio: 0 PB Ratio: 2.84 GF Score: 85/100

Q2 2020 Amedisys Inc Earnings Call Transcript

Jul 29, 2020 / 03:00PM GMT
Release Date Price: $228.82 (+6.53%)
Operator

Greetings, and welcome to the first-quarter 2020 earnings conference call. (Operator Instructions) As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, Nick Muscato. Thank you, Mr. Muscato, you may begin.

Nick Muscato
Amedisys, Inc. - VP of Strategic Finance

Thank you, operator, and welcome to the Amedisys investor conference call to discuss the results of the second quarter ended June 30, 2020. A copy of our press release, supplemental slides and related Form 8-K filing with the SEC are available on our Investor Relations page on our website.

Speaking on today's call from Amedisys will be Paul Kusserow, President and Chief Executive Officer; and Scott Ginn, Chief Financial Officer. Also joining us is Chris Gerard, Chief Operating Officer; and Dave Kemmerly, Chief Legal and Government Affairs Officer.

Before we get started with our call, I would like to remind everyone that statements made on this conference call today may constitute forward-looking statements and are protected under the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot